Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales

Current UK vaccination policy is to offer future COVID-19 booster doses to individuals at high risk of serious illness from COVID-19, but it is still uncertain which groups of the population could benefit most. In response to an urgent request from the UK Joint Committee on Vaccination and Immunisat...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:The Lancet (British edition) Ročník 400; číslo 10360; s. 1305 - 1320
Hlavní autori: Agrawal, Utkarsh, Bedston, Stuart, McCowan, Colin, Oke, Jason, Patterson, Lynsey, Robertson, Chris, Akbari, Ashley, Azcoaga-Lorenzo, Amaya, Bradley, Declan T, Fagbamigbe, Adeniyi Francis, Grange, Zoe, Hall, Elliott C R, Joy, Mark, Katikireddi, Srinivasa Vittal, Kerr, Steven, Ritchie, Lewis, Murphy, Siobhán, Owen, Rhiannon K, Rudan, Igor, Shah, Syed Ahmar, Simpson, Colin R, Torabi, Fatemeh, Tsang, Ruby S M, de Lusignan, Simon, Lyons, Ronan A, O'Reilly, Dermot, Sheikh, Aziz
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: England Elsevier Ltd 15.10.2022
Elsevier Limited
The Author(s). Published by Elsevier Ltd
Predmet:
ISSN:0140-6736, 1474-547X, 1474-547X
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Buďte prvý, kto okomentuje tento záznam!
Najprv sa musíte prihlásiť.